CXCL12 expressing organs are a target for CXCR4 positive cancer cells and blocking the CXCL12/CXCR4 interaction using neutralizing antibodies (nAb) significantly inhibits experimental metastases (108). The gene discussed is CXCR4; the disease is cancer.